Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma

NCT07730515 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

176

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-hodgkin Lymphoma
Peripheral T-cell Lymphoma

Interventions

DRUG: XNW5004 combined with CHOP (incremental)
DRUG: XNW5004 combined with CHOEP (incremental)
DRUG: XNW5004 combined with CHOP (extended)
DRUG: XNW5004 combined with CHOEP (extended)

Sponsor

Evopoint Biosciences Inc.